QQ客服 官方微博 反馈留言

	Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial
	Li, Jun; Jia, Jidong; Hou, Jin Lin; Mohamed, Rosmawati; Duan, Zhongping; Su, Minghua; Gong, Guozhong; Shang, Jia; Thi Tuyet Phuong Le; Lin, Feng
刊名	LANCET GASTROENTEROLOGY & HEPATOLOGY
	2019
卷号	4期号:2
ISSN号	2468-1253
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3534511
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Li, Jun,Jia, Jidong,Hou, Jin Lin,et al. Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial[J]. LANCET GASTROENTEROLOGY & HEPATOLOGY,2019,4(2).
APA	Li, Jun.,Jia, Jidong.,Hou, Jin Lin.,Mohamed, Rosmawati.,Duan, Zhongping.,...&Wei, Lai.(2019).Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.LANCET GASTROENTEROLOGY & HEPATOLOGY,4(2).
MLA	Li, Jun,et al."Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial".LANCET GASTROENTEROLOGY & HEPATOLOGY 4.2(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。